Introduction to health economics and decision-making: Is economics relevant for the frontline clinician?

In a climate of escalating demands for new health care services and significant constraints on new resources, the disciplines of health economics and health technology assessment (HTA) have increasingly been turned to as explicit evidence-based frameworks to help make tough health care access and reimbursement decisions. Health economics is the discipline of economics concerned with the efficient allocation of health care resources, essentially trying to maximize health benefits to society contingent upon available resources. HTA is a broader field drawing upon several disciplines, but which relies heavily upon the tools of health economics and economic evaluation. Traditionally, health economics and economic evaluation have been widely used at the political (macro) and local (meso) decision-making levels, and have progressively had an important role even at informing individual clinical decisions (micro level). The aim of this paper is to introduce readers to health economics and discuss its relevance to frontline clinicians. Particularly, the content of the paper will facilitate clinicians' understanding of the link between economics and their medical practice, and how clinical decision-making reflects on health care resource allocation.

[1]  David H. Gustafson,et al.  Decision Analysis for Healthcare Managers , 2006 .

[2]  A S Detsky,et al.  How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[3]  David A. Rochefort,et al.  COMPARATIVE MEDICAL SYSTEMS , 1996 .

[4]  Anthony J Culyer,et al.  National Institute for Clinical Excellence and its value judgments , 2004, BMJ : British Medical Journal.

[5]  Ron Goeree,et al.  Simulating an emergency department: the importance of modeling the interactions between physicians and delegates in a discrete event simulation , 2013, BMC Medical Informatics and Decision Making.

[6]  R. Pauwels,et al.  Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma. , 2003, The Journal of allergy and clinical immunology.

[7]  A. Palloni,et al.  Older adults under a mixed regime of infectious and chronic diseases. , 2012, Salud publica de Mexico.

[8]  Alejandra Duenas,et al.  Multiple criteria decision analysis for health technology assessment. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[9]  B. O'brien,et al.  Cost-benefit analyses in the health-care literature: don't judge a study by its label. , 1997, Journal of clinical epidemiology.

[10]  Alan H Williams.  Health Economics: The Cheerful Face of the Dismal Science? , 1987 .

[11]  J. Hutton.  'Health Economics' and the evolution of economic evaluation of health technologies. , 2012, Health economics.

[12]  Jordan J. Louviere,et al.  Applied Methods of Cost-Benefit Analysis in Health Care , 2010 .

[13]  Michel Boucher,et al.  Priority setting for health technology assessment at CADTH , 2010, International Journal of Technology Assessment in Health Care.

[14]  Renee J. G. Arnold,et al.  Pharmacoeconomics : From Theory to Practice , 2009 .

[15]  O. Norheim,et al.  "Saying no is no easy matter" A qualitative study of competing concerns in rationing decisions in general practice , 2005, BMC health services research.

[16]  R. Goeree,et al.  Cost-utility of laparoscopic Nissen fundoplication versus proton pump inhibitors for chronic and controlled gastroesophageal reflux disease: a 3-year prospective randomized controlled trial and economic evaluation. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[17]  Maarten J. IJzerman,et al.  Integrating patients' views into health technology assessment: Analytic hierarchy process (AHP) as a method to elicit patient preferences , 2011, International Journal of Technology Assessment in Health Care.

[18]  D. Kernick,et al.  Introduction to health economics for the medical practitioner , 2003, Postgraduate medical journal.

[19]  M. Sculpher,et al.  Decision Modelling for Health Economic Evaluation , 2006 .

[20]  E. Kluge,et al.  Resource allocation in healthcare: implications of models of medicine as a profession. , 2007, MedGenMed : Medscape general medicine.

[21]  M. Beaulieu,et al.  The role (or not) of economic evaluation at the micro level: can Bourdieu's theory provide a way forward for clinical decision-making? , 2010, Social science & medicine.

[22]  David Parkin,et al.  Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. , 2004, Health economics.

[23]  Milton C. Weinstein,et al.  A QALY is a QALY is a QALY -- Or is it? , 1988 .

[24]  A. Williams,et al.  Cost-effectiveness analysis: is it ethical? , 1992, Journal of medical ethics.

[25]  V. Diaby,et al.  Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women. , 2007, Maturitas.

[26]  E. Buskens,et al.  Cost-minimization analysis in a blind randomized trial on small-incision versus laparoscopic cholecystectomy from a societal perspective: sick leave outweighs efforts in hospital savings , 2009, Trials.

[27]  J. Merino.  Clinicians and the economic evaluation of health. , 2002, Salud publica de Mexico.

[28]  S. Pauker,et al.  The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.

[29]  Milton C Weinstein,et al.  Should physicians be gatekeepers of medical resources? , 2001, Journal of medical ethics.

[30]  R. Goeree,et al.  Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario , 2009, International Journal of Technology Assessment in Health Care.

[31]  C. Macken,et al.  Modeling targeted layered containment of an influenza pandemic in the United States , 2008, Proceedings of the National Academy of Sciences.

[32]  R. Holman,et al.  A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) , 2004, Diabetologia.

[33]  V. Diaby,et al.  A Proposed Framework for Formulary Listing in Low-Income Countries , 2011, Pharmaceutical Medicine.

[34]  Mark S. Roberts,et al.  Decision Modeling Techniques , 2000 .

[35]  S J Cunningham,et al.  An introduction to economic evaluation of health care. , 2001, Journal of orthodontics.

[36]  J R Beck,et al.  Markov Models in Medical Decision Making , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[37]  D. Kernick.  An Introduction to the Basic Principles of Health Economics for those Involved in the Development and Delivery of Headache Care , 2005, Cephalalgia : an international journal of headache.

[38]  R. Baltussen,et al.  Priority setting of health interventions: the need for multi-criteria decision analysis , 2006, Cost effectiveness and resource allocation : C/E.

[39]  B. O'brien,et al.  The death of cost-minimization analysis? , 2001, Health economics.

[40]  Emma McIntosh,et al.  Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework , 2012, PharmacoEconomics.

[41]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[42]  N. Devlin,et al.  Operationalizing Value-Based Pricing of Medicines , 2012, PharmacoEconomics.

[43]  J. Ney,et al.  Cost–Benefit Analysis: Intraoperative Neurophysiological Monitoring in Spinal Surgeries , 2013, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[44]  Daniel Polsky,et al.  Economic Evaluation in Clinical Trials , 2007 .

[45]  E. Hendriks,et al.  Cost-effectiveness of an active implementation strategy for the Dutch physiotherapy guideline for low back pain. , 2005, Health policy.

[46]  Joshua M. Epstein,et al.  Individual-based computational modeling of smallpox epidemic control strategies. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.